Medplus Health Services · tone and specificity signals across the available quarters.
Language signals
We have tweaked the incentive structure so as to consider the total sales growth at our store level which is paying off dividends. We are clearly seeing the improvement in the branded pharma uptake as well as the uptick in the private label non-farma.
On the non-farma side, if the experience is good, the product is good, the availability is good and the quality is good, there is no cap per se in terms of how far this could go.
Only 20% of our sales now come from general goods and most of our competitors are in the range of around 30 to 40 even 50%. Even a slight jump in the general good side and most of it coming from private label will definitely increase the top line and also will improve the profitability.